Hoyoung Huh
2007 - Nektar Therapeutics
In 2007, Hoyoung Huh earned a total compensation of $1.2M as Chief Operating Officer and Head of the PEGylation Business Unit at Nektar Therapeutics.
Compensation breakdown
| Bonus | $20,000 |
|---|---|
| Non-Equity Incentive Plan | $344,000 |
| Option Awards | $407,447 |
| Salary | $451,153 |
| Other | $9,182 |
| Total | $1,231,782 |
Huh received $451.2K in salary, accounting for 37% of the total pay in 2007.
Huh also received $20K in bonus, $344K in non-equity incentive plan, $407.4K in option awards and $9.2K in other compensation.
Rankings
In 2007, Hoyoung Huh's compensation ranked 3,502nd out of 8,700 executives tracked by ExecPay. In other words, Huh earned more than 59.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,502 out of 8,700 | 60th |
Division Manufacturing | 1,245 out of 3,314 | 62nd |
Major group Chemicals And Allied Products | 236 out of 746 | 68th |
Industry group Drugs | 129 out of 546 | 76th |
Industry Pharmaceutical Preparations | 97 out of 364 | 73rd |
Source: SEC filing on April 28, 2008.
Huh's colleagues
We found eight more compensation records of executives who worked with Hoyoung Huh at Nektar Therapeutics in 2007.
2007
Howard Robin
Nektar Therapeutics
Chief Executive Officer
2007
Robert Chess
Nektar Therapeutics
Chief Executive Officer
2007
David Johnston
Nektar Therapeutics
Former Senior Vice President Research and Development
2007
Timothy Harkness
Nektar Therapeutics
Chief Financial Officer
2007
Nevan Elam
Nektar Therapeutics
Senior Vice President and Head of the Pulmonary Business Unit
2007
Louis Drapeau
Nektar Therapeutics
Chief Financial Officer
2007
John Patton
Nektar Therapeutics
Chief Research Fellow
2007
John Nicholson
Nektar Therapeutics